Metallic stent I. Vascular-its basic theory and current
development-
6.Current Status of Carotid Artery Stenting
Departement of Neurosurgery, Kobe City General
Hospital
Nobuyuki Sakai, Terumasa Kuroiwa, Chiaki Mikami, Hiroshi
Manaka, Hirotoshi Imamura, Hidemitsu Adachi, Shuichi Kobayashi,
Satoshi Nakao, Izumi Nagata, Waro Taki, Haruhiko Kikuchi
Abstract
Carotid artery stenting(CAS) has been developed in recent years
as an alternative to carotid endarterectomy(CEA). We report our
clinical experience of CAS and evaluate the feasibility and efficacy
of this treatment. Since 1997 Feb, 237 patients(199 male, aged
50~85, mean 67.5),235 carotid artery stenosis (109 symptomatic,
126 asymptomatic)procedures. 5 aortitis, 1 FMD, and 6 dissection
were treated with 259 endovascular stenting. Our method in now
is as follows; under local anesthesia, transfemoral approach,
using 9F guiding catheter, pre-dilation with low profile 3.0~3.5a
PTA balloon with 0.014" long wire, and self-expandable stent(Easy
Wallstent, SMART stent, AccuLink-II) deployment. Since 1998 Dec,
we have used our originally made distal balloon protective system
in post PTA. Embolic events were checked by TCD, MRI/DWI and
histopathological study by aspirated blood.
Procedural success was 99.2%, and complication occurred in 2(0.77%)
major and 6(2.3%) minor stroke without mortality. However, embolic
signals and debri were detected in all cases with TCD and histopathological
study, and procedure related ischemic lesions were detected by
MRI/DWI study in about 50% of cases. Restenosis occurred in 12/155(7.7%)
of F/U angiography, 6~50 months after treatment. No complication
occurred in re-treatment.
Conclusions : Our results indicate that carotid stenting may
well offer a similar safety profile and efficacy to those of
carotid endarterectomy. The future status of carotid artery stenting
will be determined with randomized trials and improvement in
devices, technique and safety.
Key words
● Carotid artery
● PTA
● Stent
● Protection
|